Dialysis industry news

Stories from the dialysis comunity across the globe.



Research and Markets: India Nephrology and Urology Devices Market Outlook ... - Business Wire (press release) PDF Print

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/p6g2z4/india_nephrology_a) has announced the addition of GlobalData's new report "India Nephrology and Urology Devices Market Outlook to 2018 - Incontinence Devices, Renal Dialysis Equipment and Lithotripters" to their offering.

“India Nephrology and Urology Devices Market Outlook to 2018 - Incontinence Devices, Renal Dialysis Equipment and Lithotripters”

This new report provides key market data on the India Nephrology and Urology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within three market categories - Incontinence Devices, Lithotripters and Renal Dialysis Equipment. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope:

- Market size and company share data for Nephrology and Urology Devices market categories - Incontinence Devices, Lithotripters and Renal Dialysis Equipment.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within three market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the three market categories.

- Global corporate-level profiles of key companies operating within the India Nephrology and Urology Devicesmarket.

- Key players covered include Svenska Cellulosa Aktiebolaget SCA, Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, First Quality Enterprises, Inc., Kimberly-Clark Corporation, Allengers Medical Systems Ltd. and others.

Reasons to Buy:

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the India Nephrology and Urology Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Companies Mentioned:

- Svenska Cellulosa Aktiebolaget Sca

- Baxter International Inc.

- Fresenius Medical Care Ag & Co. Kgaa

- First Quality Enterprises, Inc.

- Kimberly-Clark Corporation

- Allengers Medical Systems Ltd.

- Dornier Medtech Gmbh

- Nipro Corporation

- Nikkiso Co., Ltd.

- Hartmann Group

- Siemens Healthcare

- Coloplast A/S

- Covidien Plc

- B. Braun Melsungen Ag

- Gambro Ab

- C. R. Bard, Inc

- Direxgroup

- Ontex International N.V.

For more information visithttp://www.researchandmarkets.com/research/p6g2z4/india_nephrology_a

Source: GlobalData

...

 
Research and Markets: India Nephrology and Urology Devices ... - Business Wire (press release) PDF Print

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/p6g2z4/india_nephrology_a) has announced the addition of GlobalData's new report "India Nephrology and Urology Devices Market Outlook to 2018 - Incontinence Devices, Renal Dialysis Equipment and Lithotripters" to their offering.

“India Nephrology and Urology Devices Market Outlook to 2018 - Incontinence Devices, Renal Dialysis Equipment and Lithotripters”

This new report provides key market data on the India Nephrology and Urology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within three market categories - Incontinence Devices, Lithotripters and Renal Dialysis Equipment. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope:

- Market size and company share data for Nephrology and Urology Devices market categories - Incontinence Devices, Lithotripters and Renal Dialysis Equipment.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within three market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the three market categories.

- Global corporate-level profiles of key companies operating within the India Nephrology and Urology Devicesmarket.

- Key players covered include Svenska Cellulosa Aktiebolaget SCA, Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, First Quality Enterprises, Inc., Kimberly-Clark Corporation, Allengers Medical Systems Ltd. and others.

Reasons to Buy:

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the India Nephrology and Urology Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Companies Mentioned:

- Svenska Cellulosa Aktiebolaget Sca

- Baxter International Inc.

- Fresenius Medical Care Ag & Co. Kgaa

- First Quality Enterprises, Inc.

- Kimberly-Clark Corporation

- Allengers Medical Systems Ltd.

- Dornier Medtech Gmbh

- Nipro Corporation

- Nikkiso Co., Ltd.

- Hartmann Group

- Siemens Healthcare

- Coloplast A/S

- Covidien Plc

- B. Braun Melsungen Ag

- Gambro Ab

- C. R. Bard, Inc

- Direxgroup

- Ontex International N.V.

For more information visithttp://www.researchandmarkets.com/research/p6g2z4/india_nephrology_a

Source: GlobalData

...

 
Foot Problems Boost Mortality in Diabetic Dialysis Patients - Renal Business Today PDF Print

PHILADELPHIA—Diabetic patients on dialysis who have foot ulcers or who have undergone a foot amputation have a much higher mortality rate at two years than diabetic patients on dialysis without these pathologies, British investigators reported at the 72nd Scientific Sessions of the American Diabetes Association.

Agbor Ndip, MD, specialist registrar and senior clinical fellow at the Manchester Royal Infirmary, and colleagues examined the impact of foot ulcers and amputations on mortality in 192 diabetic patients undergoing dialysis a their institution.

Study participants underwent comprehensive foot examination at enrollment to assess for neuropathy, peripheral arterial disease, foot deformities, and foot ulcers/amputation.

Overall, 102 patients, or 53.1 percent, had died after two years. Thirty-five (59.3%) of 59 patients who had a foot ulcer at baseline had died after two years compared with 55 (41.4%) of 133 patients who did not have a foot ulcer at baseline. Additionally, 26 (74.3%) of 35 patients who had a foot amputation at baseline were dead at two years versus 64 (40.8%) of 157 patients without amputation at baseline. The differences in two-year mortality rates between patients with and without foot pathology were statistically significant.

Foot disease was a strong predictor of mortality on multivariate analysis that controlled for the type and duration of diabetes, age, gender, and patient history of retinopathy, ischemic heart disease, congestive heart failure, cerebrovascular disease, amputation, foot ulcer, peripheral vascular disease, and neuropathy, an active foot ulcer, or poor baseline glycemic control.

...

 
In your experience, what do you think is the single biggest ... - Renal and Urology News PDF Print

In your experience, what do you think is the single biggest ...
Renal and Urology News
Lack of adherence to therapeutic regimens is a major reason why patients fail to control certain diseases and conditions.

...

 
Giving kids a better life - Whangarei Leader PDF Print

ESTHER LAUAKI Last updated 05:00 19/06/2012 Kidney Kids ESTHER LAUAKI

HEALTHY CONTRIBUTION: Paediatric nephrologist Dr William Wong from Starship children's hospital with one of two haemodialysis machines that will help treat kids with kidney disease.

There are only four nephrologists in New Zealand and Dr William Wong is one of them.

It is likely you will have met him if yours is one of the 1200 families that has a child born with abnormal kidneys or congenital kidney disease.

Dr Wong is the director of paediatric nephrology at Starship children's hospital and has served in the field for 18 years.

He was the second kidney specialist in this country after training under New Zealand's first nephrologist Dr Max Morris 22 years ago.

"I enjoy it because I like a challenge," he says. "You see the patients and you get them well again. They run around and they are well. It's very gratifying to see. Within a few weeks of their transplant, they are living almost normal lives. It's an area which is often changing with a lot of new development which keeps things exciting."

Dr Wong has been seeing some of his patients since they were babies and will be with them throughout their teen years too.

"We start off with dialysis treatment. That is a big part of our work. Children are often very sick at the beginning and we've got to get them back to a state where they are able to lead healthier, better lives. That is very resource intensive and we need machines for that ... patients can't survive without dialysis."

Children on peritoneal dialysis can be treated at home but haemodialysis requires kids to visit the hospital and is reserved for serious cases.

A haemodialysis machine cleans the patient's blood by running it through an artificial kidney before returning it to the body.

That means sitting still for four-hour sessions, three or four times a week and it costs roughly $100,000 a year to help one person, Dr Wong says.

Starship has two haemodialysis machines and four children on haemodialysis at present.

The Mad Butcher and Suburban Newspapers Community Trust and Kidney Kids, is fundraising to buy four haemodialysis machines for the first-ever national dedicated Paediatric Haemodialysis Unit at Starship.

It has called the exercise Project Kidney and needs $132,000 to achieve its goal and help make a difference for the many youngsters affected from all over the country.

Any extra proceeds will go towards the unit and additional equipment.

"Just a dollar from each of our readers would pay for these machines many times over," trust chairman and Suburban Newspapers general manager David Penny says.

"This is one of those causes that we should all support in whatever way we can. Kidney disease is widespread and could affect any one of us or our families," he says.

Dr Wong says diabetes, diet and other lifestyle choices are often factors contributing to the problem among adults.

But many children are the victims of genetics. "They're born with it and the causes are evident in children from birth right through to 16 or 17 years old," he says.

HOW YOU CAN HELP:
Donations can be made at the Western Leader, 2 Waipareira Ave, Henderson, or posted to Project Kidney, Mad Butcher and Suburban Newspapers Community Trust, PO Box 92815, Penrose, Auckland. You can also bank your contribution direct into the Project Kidney account 03 0243 0268896 00 at any branch of Westpac.

- © Fairfax NZ News

Sponsored links

...

 
<< Start < Prev 551 552 553 554 555 556 557 558 559 560 Next > End >>

Page 554 of 4210
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.